Confirmed Invited Speakers
A distinguished panel of world-renowned speakers have already confirmed their participation to the CLEPSO Meeting 2018:
Lucia ALTUCCI, University of Naples, Naples, Italy
From Single-Target to Multi-Target Epigenetic Therapeutics
Jesper Boje ANDERSEN, Univesity of Copenhagen, Copenhagen, Denmark
Epigenetics of Cholangiocarcinoma
Wim Van Den BERGHE, University of Antwerp, Belgium
BRCA Methylation Changes in Cancer and Cardiovascular Disease
Fabio COPPEDÈ, University of Pisa, Pisa, Italy
Pharmacoepigenetics and Pharmacoepigenomics of GastrointestinalCancers
Jim DAVIE, University of Manitoba, Winnipeg, Canada
Epigenetic Profiling of Fetal Alcohol Syndrome and Type II Diabetes
James D. FLANAGAN, Imperial College of London, London, UK
Epigenome-Wide Association Studies for Breast Cancer Risk and Risk Factors.
Kirsten Grønbæk, Copenhagen Biocenter, Copenhagen, Denmark
Modulation of the Immune System by Epigenetic Therapy
Christian HEDRICH, University of Liverpool, Liverpool, UK
On the Epigenetics of Systemic Lupus Erythematosus
Sam KEATING, Radboud Center for Infectious Diseases, Nijmegen, The Netherlands
Epigenetics and the Immune System
Vessela N. KRISTENSEN, University of Oslo, Oslo, Norway
DNA Methylation at Enhancers Identifies Distinct Breast Cancer Lineages.
Jonathan LICHT, University of Florida, Gainesville, FL, USA
Epigenetic Dysregulation in Lymphoid Malignancy
Charlotte LING, University of Lund, Malmö, Sweden
The Effects of High Glucose Exposure on Global Gene Expression and DNA Methylation in Human Pancreatic Islets.
Janos MINAROVITS, University of Szeged, Szeged, Hungary
Epigenetic Dysregulation Through Infectious Disease
Pamela MUNSTER, University of California, San Francisco CA, USA
Select HDAC Enzyme Expression as Host Specific Biomarkers
Arpad PATAI, Semmelweis University, Budapest, Hungary
Clinical Implications of DNA Methylation in Inflammatory Bowel Disease, Colorectal Polyps and Cancer
Gerd PFEIFER, Cancer for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA
Oxidation of 5-Methylcytosine in Development and Disease
Edyta RESZKA, Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Diseases, Lodz, Poland
Circadian Gene Variants and Breast Cancer.
Bart P.F. RUTTEN, Maastricht University Medical Centre, Maastricht, the Netherlands
On the Epigenetics of Aging, Neurodegeneration and Brain Cancer
David S. SCHRUMP, NIH, Bethesda, MD, USA
Epigenetics of Malignant Pleural Mesothelioma
Anton SHOSTAK, University of Heidelberg, Heidelberg, Germany
Circadian Clock, Cell Division, and Cancer: From Molecules to Organism.
Alessio SQUASSINA, University of Cagliari, Cagliari, Italy
Recent Trends on the Role of Epigenomics, Metabolomics and Noncoding RNAs in Rationalizing Mood Stabilizing Treatment
Henk STUNNENBERG, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
The Interplay of Epigenetic Marks During Stem Cell Differentiation and Development.